Drug-drug interactions at hospital admission in geriatric patients in a single facility: A retrospective study

International Journal of Clinical Pharmacology and Therapeutics

Volumn 50, Issue 6, 2012, Pages 426-430

  Sánchez Arenas, Rosalinda ^a   Sánchez García, Sergio ^a   García Peña, Carmen ^a   García Gonzàlez, Jose Juan ^a   Rivera Garcia, Blanca Elsa ^b   Juárez Cedillo, Teresa ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b General Hospital Zone 24   (Mexico)

Author keywords

Geriatric patients; Hospital setting; Potential drug drug interactions (PDDI)

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CARBONATE; CAPTOPRIL; CLOPIDOGREL; DIGOXIN; ENOXAPARIN; ERYTHROMYCIN; FUROSEMIDE; GATIFLOXACIN; HALOPERIDOL; LEVODOPA; METOCLOPRAMIDE; METOPROLOL; PARACETAMOL; PHENYTOIN; PREDNISONE; SALBUTAMOL; SPIRONOLACTONE; SULFAMETHOXAZOLE; WARFARIN;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; DISEASE SEVERITY; DRUG ANTAGONISM; FEMALE; GERIATRIC PATIENT; HOSPITAL ADMISSION; HUMAN; INTERNAL MEDICINE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT INFORMATION; POTENTIAL DRUG DRUG INTERACTION; PRESCRIPTION; QUALITY OF LIFE; RETROSPECTIVE STUDY;

AGED; DRUG INTERACTIONS; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84861826693     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201551     Document Type: Article

References (11)

1. Viktil KKBH, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007; 63: 187-195. doi:10.1111/j.1365-2125.2006. 02744.x PubMed (Pubitemid 46072105)
2. Reimche LFA, Forster AJ, van Walraven C. Incidence and contributors to potential drug-drug interactions in hospitalized patients. J Clin Pharmacol. 2011; 51: 1043-1050. doi:10.1177/0091270010378858 PubMed
3. Paterno MDMS, Maviglia SM, Gorman PN, Seger DL, Yoshida E, Seger AC, Bates DW, Gandhi TK. Tiering drug-drug interaction alerts by severity increases compliance rates. J Am Med Inform Assoc. 2009; 16: 40-46. doi:10.1197/jamia. M2808 PubMed
4. Hines LEMJ, Murphy JE. Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother. 2011; 9: 364-377. doi:10.1016/j.amjopharm.2011.10.004 PubMed
5. Gray CLGC, Gardner C. Adverse drug events in the elderly: an ongoing problem. J Manag Care Pharm. 2009; 15: 568-571. PubMed
6. Glassman PABP, Belperio P, Simon B, Lanto A, Lee M. Exposure to automated drug alerts over time: effects on clinicians' knowledge and perceptions. Med Care. 2006; 44: 250-256. doi:10.1097/01.mlr.0000199849.08389.91 PubMed (Pubitemid 43755452)
7. Moura CSAF, Acurcio FA, Belo NO. Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009; 12: 266-272. PubMed
8. Krähenbühl-Melcher A Sr, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007; 30: 379-407. PubMed (Pubitemid 46740336)
9. No authors listed. Implementation of the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). Epidemiol Bull. 1997; 18: 1-4.
10. Reax. MaD-. 〈http://www.micromedex.com/〉. Accessed 18. 2009.
11. Puckett WH Jr, Visconti JA. An epidemiological study of the clinical significance of drug-drug interactions in a private community hospital. Am J Hosp Pharm. 1971; 28: 247-253.